102 related articles for article (PubMed ID: 10386230)
1. Effects of heparin on vascular dysfunction in diabetic rats.
Oturai PS
Clin Exp Pharmacol Physiol; 1999; 26(5-6):411-4. PubMed ID: 10386230
[TBL] [Abstract][Full Text] [Related]
2. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Nielsen S; Schmitz A; Bacher T; Rehling M; Ingerslev J; Mogensen CE
Diabetologia; 1999 Jan; 42(1):60-7. PubMed ID: 10027580
[TBL] [Abstract][Full Text] [Related]
3. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
Ido Y; Kilo C; Williamson JR
Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
[TBL] [Abstract][Full Text] [Related]
4. Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients.
Vervoort G; Lutterman JA; Smits P; Berden JH; Wetzels JF
J Hypertens; 1999 Dec; 17(12 Pt 2):1911-6. PubMed ID: 10703889
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
6. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
[TBL] [Abstract][Full Text] [Related]
7. Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat.
van den Born J; van Kraats AA; Hill S; Bakker MA; Berden JH
Nephrol Dial Transplant; 1997; 12 Suppl 2():27-31. PubMed ID: 9269696
[TBL] [Abstract][Full Text] [Related]
8. Effect of enalapril on the microvascular albumin leakage in patients with diabetic microangiopathy and normal or mildly elevated blood pressure.
Chagnac A; Korzets A; Zevin D; Wender T; Carmon G; Hirsh J; Gafter U; Levi J
Clin Nephrol; 1994 Mar; 41(3):144-9. PubMed ID: 8187356
[TBL] [Abstract][Full Text] [Related]
9. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
Guo H; Gan L; Yu Z
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
[TBL] [Abstract][Full Text] [Related]
10. Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.
Huijberts MS; Wolffenbuttel BH; Crijns FR; Nieuwenhuijzen Kruseman AC; Bemelmans MH; Struijker Boudier HA
Diabetologia; 1994 Jan; 37(1):10-4. PubMed ID: 8150221
[TBL] [Abstract][Full Text] [Related]
11. Early onset of increased transcapillary albumin escape in awake diabetic rats.
Tucker BJ
Diabetes; 1990 Aug; 39(8):919-23. PubMed ID: 2142657
[TBL] [Abstract][Full Text] [Related]
12. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.
Pugliese G; Tilton RG; Speedy A; Chang K; Santarelli E; Province MA; Eades D; Sherman WR; Williamson JR
Diabetologia; 1989 Dec; 32(12):845-57. PubMed ID: 2533117
[TBL] [Abstract][Full Text] [Related]
13. Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy.
Parving HH; Kastrup J; Smidt UM
Diabetologia; 1985 Nov; 28(11):797-801. PubMed ID: 4085693
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
Anbar HS; Shehatou GS; Suddek GM; Gameil NM
Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide in streptozotocin-induced diabetes mellitus in rats.
Maree A; Peer G; Iaina A; Blum M; Wollman Y; Csernihovsky T; Silverberg DS; Cabili S
Clin Sci (Lond); 1996 May; 90(5):379-84. PubMed ID: 8665775
[TBL] [Abstract][Full Text] [Related]
16. Gliquidone versus metformin: differential effects on aorta in streptozotocin induced diabetic rats.
Tan Z; Xu Z; Gui Q; Wu W; Yang Y
Chin Med J (Engl); 2014; 127(7):1298-303. PubMed ID: 24709184
[TBL] [Abstract][Full Text] [Related]
17. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats.
Greive KA; Eppel GA; Reeve S; Smith AI; Jerums G; Comper WD
Am J Kidney Dis; 2001 Jul; 38(1):144-52. PubMed ID: 11431194
[TBL] [Abstract][Full Text] [Related]
18. [Effects of low molecular weight heparin on vascular endothelial growth factor expression of early diabetic nephropathy].
Gan LY; Yu ZY; Cai MS; Zhao HP; Li X
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):382-5. PubMed ID: 16086057
[TBL] [Abstract][Full Text] [Related]
19. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
20. Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
Oturai PS; Christensen M; Rolin B; Pedersen KE; Mortensen SB; Boel E
Metabolism; 2000 Aug; 49(8):996-1000. PubMed ID: 10954016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
